vs

Side-by-side financial comparison of CuriosityStream Inc. (CURI) and SuperCom Ltd (SPCB). Click either name above to swap in a different company.

CuriosityStream Inc. is the larger business by last-quarter revenue ($19.2M vs $14.2M, roughly 1.4× SuperCom Ltd). SuperCom Ltd runs the higher net margin — 37.5% vs -19.7%, a 57.2% gap on every dollar of revenue. On growth, CuriosityStream Inc. posted the faster year-over-year revenue change (35.8% vs -1.5%). CuriosityStream Inc. produced more free cash flow last quarter ($3.9M vs $-3.6M).

Curiosity Stream Inc., formerly branded as CuriosityStream, is an American media company and over-the-top subscription video streaming service which offers documentary programming including films, series, and TV shows. The company offers a video on demand subscription service branded as "Curiosity Stream" and a linear broadcast television channel known as the Curiosity Channel through various services including FuboTV and The Roku Channel.

Super.com is a technology company headquartered in San Francisco and co-founded by Hussein Fazal and Henry Shi. The company provides financial services, including reward programs and travel bookings.

CURI vs SPCB — Head-to-Head

Bigger by revenue
CURI
CURI
1.4× larger
CURI
$19.2M
$14.2M
SPCB
Growing faster (revenue YoY)
CURI
CURI
+37.3% gap
CURI
35.8%
-1.5%
SPCB
Higher net margin
SPCB
SPCB
57.2% more per $
SPCB
37.5%
-19.7%
CURI
More free cash flow
CURI
CURI
$7.5M more FCF
CURI
$3.9M
$-3.6M
SPCB

Income Statement — Q4 FY2025 vs Q2 FY2025

Metric
CURI
CURI
SPCB
SPCB
Revenue
$19.2M
$14.2M
Net Profit
$-3.8M
$5.3M
Gross Margin
61.2%
Operating Margin
-17.6%
16.3%
Net Margin
-19.7%
37.5%
Revenue YoY
35.8%
-1.5%
Net Profit YoY
-34.6%
79.5%
EPS (diluted)
$-0.07
$1.32

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CURI
CURI
SPCB
SPCB
Q4 25
$19.2M
Q3 25
$18.4M
Q2 25
$19.0M
$14.2M
Q1 25
$15.1M
Q4 24
$14.1M
Q3 24
$12.6M
Q2 24
$12.4M
$14.4M
Q1 24
$12.0M
Net Profit
CURI
CURI
SPCB
SPCB
Q4 25
$-3.8M
Q3 25
$-3.7M
Q2 25
$784.0K
$5.3M
Q1 25
$319.0K
Q4 24
$-2.8M
Q3 24
$-3.1M
Q2 24
$-2.0M
$3.0M
Q1 24
$-5.0M
Gross Margin
CURI
CURI
SPCB
SPCB
Q4 25
Q3 25
Q2 25
61.2%
Q1 25
Q4 24
Q3 24
Q2 24
52.3%
Q1 24
Operating Margin
CURI
CURI
SPCB
SPCB
Q4 25
-17.6%
Q3 25
-24.5%
Q2 25
2.5%
16.3%
Q1 25
0.5%
Q4 24
-27.4%
Q3 24
-25.8%
Q2 24
-20.6%
7.7%
Q1 24
-30.4%
Net Margin
CURI
CURI
SPCB
SPCB
Q4 25
-19.7%
Q3 25
-20.4%
Q2 25
4.1%
37.5%
Q1 25
2.1%
Q4 24
-19.9%
Q3 24
-24.3%
Q2 24
-16.4%
20.6%
Q1 24
-42.0%
EPS (diluted)
CURI
CURI
SPCB
SPCB
Q4 25
$-0.07
Q3 25
$-0.06
Q2 25
$0.01
$1.32
Q1 25
$0.01
Q4 24
$-0.05
Q3 24
$-0.06
Q2 24
$-0.04
$1.19
Q1 24
$-0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CURI
CURI
SPCB
SPCB
Cash + ST InvestmentsLiquidity on hand
$27.3M
$15.0M
Total DebtLower is stronger
$23.6M
Stockholders' EquityBook value
$41.5M
$37.3M
Total Assets
$75.7M
$65.5M
Debt / EquityLower = less leverage
0.63×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CURI
CURI
SPCB
SPCB
Q4 25
$27.3M
Q3 25
$27.8M
Q2 25
$28.1M
$15.0M
Q1 25
$33.4M
Q4 24
$32.1M
Q3 24
$33.2M
Q2 24
$39.5M
$5.7M
Q1 24
$38.8M
Total Debt
CURI
CURI
SPCB
SPCB
Q4 25
Q3 25
Q2 25
$23.6M
Q1 25
Q4 24
Q3 24
Q2 24
$29.2M
Q1 24
Stockholders' Equity
CURI
CURI
SPCB
SPCB
Q4 25
$41.5M
Q3 25
$47.2M
Q2 25
$49.8M
$37.3M
Q1 25
$58.1M
Q4 24
$57.8M
Q3 24
$62.2M
Q2 24
$64.8M
$13.8M
Q1 24
$67.0M
Total Assets
CURI
CURI
SPCB
SPCB
Q4 25
$75.7M
Q3 25
$74.7M
Q2 25
$78.7M
$65.5M
Q1 25
$85.3M
Q4 24
$86.2M
Q3 24
$87.6M
Q2 24
$90.9M
$49.6M
Q1 24
$94.6M
Debt / Equity
CURI
CURI
SPCB
SPCB
Q4 25
Q3 25
Q2 25
0.63×
Q1 25
Q4 24
Q3 24
Q2 24
2.11×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CURI
CURI
SPCB
SPCB
Operating Cash FlowLast quarter
$4.0M
$-2.2M
Free Cash FlowOCF − Capex
$3.9M
$-3.6M
FCF MarginFCF / Revenue
20.5%
-25.3%
Capex IntensityCapex / Revenue
0.1%
10.0%
Cash ConversionOCF / Net Profit
-0.41×
TTM Free Cash FlowTrailing 4 quarters
$-14.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CURI
CURI
SPCB
SPCB
Q4 25
$4.0M
Q3 25
$4.4M
Q2 25
$2.8M
$-2.2M
Q1 25
$1.9M
Q4 24
$3.0M
Q3 24
$2.3M
Q2 24
$2.2M
$-950.0K
Q1 24
$666.0K
Free Cash Flow
CURI
CURI
SPCB
SPCB
Q4 25
$3.9M
Q3 25
Q2 25
$-3.6M
Q1 25
$1.8M
Q4 24
Q3 24
Q2 24
$-1.6M
Q1 24
FCF Margin
CURI
CURI
SPCB
SPCB
Q4 25
20.5%
Q3 25
Q2 25
-25.3%
Q1 25
12.2%
Q4 24
Q3 24
Q2 24
-10.8%
Q1 24
Capex Intensity
CURI
CURI
SPCB
SPCB
Q4 25
0.1%
Q3 25
0.0%
Q2 25
0.0%
10.0%
Q1 25
0.5%
Q4 24
0.0%
Q3 24
0.0%
Q2 24
0.0%
4.2%
Q1 24
0.0%
Cash Conversion
CURI
CURI
SPCB
SPCB
Q4 25
Q3 25
Q2 25
3.56×
-0.41×
Q1 25
6.03×
Q4 24
Q3 24
Q2 24
-0.32×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons